1461102145-80dd625f-17fe-4d6d-91f3-8a6ff2c5d960

1. A potency-extending agent of a botulinum toxin type-A product, the potency-extending agent produced by mixing 1 ml of distilled water for injection with 84-86 mg of dextrose, as a main component, 4.18-4.38 mg of sodium chloride, as a first stabilizer, and 9-11 mg of trehalose or sucrose, as a second stabilizer.
2. The potency-extending agent of claim 1, wherein the potency-extending agent further includes 0.9-1.1 mg of lidocaine, as a pain killer, to mitigate a patient’s pain upon injection.
3. The potency-extending agent of claim 1, wherein the potency-extending agent increases the potency of the botulinum toxin type-A product by 75% without potency loss after diluting the botulinum toxin type-A product and the potency-extending agent allows the botulinum toxin type-A product to have a preservation period of 18 to 24 months without potency loss at a low temperature of 2-8\xb0 C. after dilution.
4. A potency-extending agent of a botulinum toxin type-A product, the potency-extending agent produced by mixing 1 ml of distilled water for injection with 84-86 mg of dextrose, as a main component, 4.18-4.38 mg of sodium chloride, as a first stabilizer, and 4.5-5.5 mg of trehalose and 4.5-5.5mg of sucrose, as a second stabilizer.
5. The potency-extending agent of claim 4, wherein the potency-extending agent limber includes 0.9-1.1 mg of lidocaine, as a pain killer, to mitigate a patient’s pain upon injection.
6. The potency-extending agent of claim 4, wherein the potency-extending agent increases the potency of the botulinum toxin type-A product by 75% without potency loss after diluting the botulinum toxin type-A product and the potency-extending agent allows the botulinum toxin type-A product to have a preservation period of 18 to 24 months without potency loss at a low temperature of 2-8\xb0 C. after dilution.
7. A potency-extending agent of a botulinum toxin type-A product, the potency-extending agent comprises 1 ml of distilled water 85 of dextrose, 4.28 mg of sodium chloride, and 10 mg of trehalose.
8. The potency-extending agent of claim 7, wherein the potency-extending agent increases the potency of the botulinum toxin type-A product by 75% without potency loss after diluting the botulinum toxin type-A product and the potency-extending agent allows the botulinum toxin type-A product to have a preservation period of 12 to 15 months without potency loss at a low temperature of 2-8\xb0 C. after dilution.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A sectional adapter of clamping holder for automobiles, comprising:
a clamping holder, being a retainer mounted inside an S automobile by a fixing base, and having a clamping member for clamping an electronic appliance; characterized in that said clamping holder comprising a socket disposed at the rear end of a main body of said clamping holder and said socket being coupled to a connector of an adapter, and said adapter being coupled onto said clamping holder by a snap-in member, and having a plug of different forms disposed at the front end of the upper section of said adapter for connecting to said appliance selected from a collection of a mobile phone, a PDA, and a palm game.
2. The sectional adapter of clamping holder for automobiles of claim 1, wherein said adapter is electrically coupled to an internal circuit in said main body of said clamping holder through said connector, and said internal circuit of said main body is connected to a power supply socket in said automobile.
3. The sectional adapter of clamping holder for automobiles of claim 2, wherein said adapter has a voltage transform circuit for changing voltages for power supply.
4. The sectional adapter of clamping holder for automobiles of claim 2, wherein said adapter has a plurality of voltage transform circuits for transforming voltages for power supply.